ANKRD18CP: A Potential Drug Target and Biomarker (G101926917)

Target Name: ANKRD18CP

NCBI ID: G101926917

ANKRD18CP

Other Name(s): Ankyrin repeat domain-containing protein 18B-like | ankyrin repeat domain 18C, pseudogene | LOC101926917

ANKRD18CP: A Potential Drug Target and Biomarker

Ankyrin repeat domain-containing protein 18B (ANKRD18CP) is a protein that has been identified as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, diabetes, and cancer. Its unique structure and function make it an attractive target for drug development, as well as a diagnostic tool for the detection of these diseases.

The ANKRD18CP protein is a member of the superfamily of ANK-repeat proteins, which are characterized by the repeated sequence of the amino acid Asp-Glu-His. ANK-repeat proteins are known for their ability to form a disulfide bond, which can interact with a variety of molecules, including small molecules, ions, and diseases.

One of the unique features of ANKRD18CP is its high level of cross-talk with other proteins that are involved in cellular signaling pathways. This makes it a promising target for drugs that can modulate its activity and improve therapeutic outcomes. Additionally, ANKRD18CP has been shown to play a role in the regulation of cellular processes that are relevant to a wide range of diseases, including neurodegenerative disorders, diabetes, and cancer.

The ANKRD18CP protein is involved in a number of cellular processes that are crucial for normal cell function and survival. One of its key functions is the regulation of the cytoskeleton, which is the structure that gives cells their shape and provides support for various cellular processes. ANKRD18CP is involved in the assembly and disassembly of the cytoskeleton, as well as the regulation of the cytoskeleton-associated protein complex (CAP), which is responsible for maintaining the stability of the cytoskeleton.

In addition to its role in cytoskeleton regulation, ANKRD18CP is also involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. ANKRD18CP has been shown to play a role in the regulation of cell adhesion, as well as the formation of tight junctions, which are a type of cell-cell adhesion structure.

The ANKRD18CP protein is also involved in the regulation of cell survival and apoptosis, which are processes that are crucial for the regulation of cellular life cycle. ANKRD18CP has been shown to play a role in the regulation of cell apoptosis, as well as the regulation of cell cycle progression.

In addition to its role in cellular processes, ANKRD18CP has also been shown to play a role in the regulation of cellular signaling pathways. It is involved in the regulation of several signaling pathways that are involved in cellular processes, including the NF-kappa pathway, the PI3K/AKT pathway, and the Wnt/FGF pathway.

The ANKRD18CP protein is also involved in the regulation of inflammation, which is a critical immune response that helps maintain the health and integrity of the body. ANKRD18CP has been shown to play a role in the regulation of inflammation, as well as the regulation of immune cell function.

In conclusion, ANKRD18CP is a protein that has a wide range of functions in cellular processes, including cytoskeleton regulation, cell adhesion, cell survival and apoptosis, and signaling pathways. Its unique structure and function make it an attractive target for drug development and a diagnostic tool for a wide range of diseases. Further research is needed to fully understand the role of ANKRD18CP in cellular processes and its potential as a drug target and biomarker.

Protein Name: Ankyrin Repeat Domain 18C, Pseudogene

The "ANKRD18CP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD18CP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets